Innovotech (CVE:IOT) Hits New 1-Year Low – Should You Sell?

Shares of Innovotech Inc. (CVE:IOTGet Free Report) reached a new 52-week low during mid-day trading on Monday . The company traded as low as C$0.10 and last traded at C$0.10, with a volume of 223914 shares changing hands. The stock had previously closed at C$0.11.

Innovotech Stock Up 5.0%

The company has a quick ratio of 5.81, a current ratio of 2.63 and a debt-to-equity ratio of 12.55. The business has a 50-day moving average price of C$0.15 and a 200-day moving average price of C$0.21. The firm has a market capitalization of C$5.72 million, a PE ratio of -15.42 and a beta of 2.62.

About Innovotech

(Get Free Report)

Innovotech Inc provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services.

Read More

Receive News & Ratings for Innovotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovotech and related companies with MarketBeat.com's FREE daily email newsletter.